Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.52 |
| ▸ | VCAM1 | P19320 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.50 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.50 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.50 |
| ▸ | CASP6 | P55212 | 1/20 | 0.46 |
| ▸ | TTR | P02766 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28155919 | 0.87 | TSHR (0.47) | GPR35VCAM1ALDH1A1TSHRTDP1 | |
| SCHEMBL4324556 | 0.85 | VCAM1 (0.63) | GPR35VCAM1ALDH1A1TSHRTDP1 | |
| SCHEMBL3329098 | 0.83 | GPR35 (0.48) | GPR35VCAM1ALDH1A1TSHRCASP6 | |
| SCHEMBL3146159 | 0.83 | CASP6 (0.60) | GPR35VCAM1ALDH1A1TSHRTDP1 | |
| SCHEMBL4893026 | 0.83 | GPR35 (0.69) | GPR35VCAM1ALDH1A1TSHRTDP1 | |
| SCHEMBL6570802 | 0.83 | CYP3A4 (0.59) | GPR35VCAM1ALDH1A1TSHRTDP1 | |
| SCHEMBL15275446 | 0.82 | LMNA (0.49) | GPR35VCAM1ALDH1A1TSHRCYP3A4 | |
| SCHEMBL11389414 | 0.82 | VCAM1 (0.50) | GPR35VCAM1ALDH1A1TSHRTDP1 | |
| Hydrochloric Acid SCHEMBL10571715 | 0.82 | CASP6 (0.58) | GPR35VCAM1ALDH1A1TSHRTDP1 | |
| SCHEMBL31124783 | 0.82 | TSHR (0.49) | GPR35VCAM1ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060052421-A1 | Conjugation agent | EASTMAN KODAK COMPANY | 2006-03-09 | — | — | US | disclosed |
| US-4855410-A | Process for the preparation of fibre-reactive azo compounds containing a phenylenediamine diazo component | CIBA-GEIGY CORPORATION (US) | 1989-08-08 | — | — | US | disclosed |
| US-4568350-A | Cold pad-batch process for dyeing silk or silk-containing fiber blends with reactive dyes | CIBA-GEIGY CORPORATION (US) | 1986-02-04 | — | — | US | disclosed |
| US-4560388-A | WITH SULFO GROUP CONTAINING FIBER REACTIVE DYE | CIBA-GEIGY CORPORATION (US) | 1985-12-24 | — | — | US | disclosed |
| US-4394310-A | DIAZOTIZATION, CYCLIZATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-07-19 | — | — | US | disclosed |
| US-4330469-A | Reactive dyes, processes for their manufacture and their use | CIBA-GEIGY CORPORATION (US) | 1982-05-18 | — | — | US | disclosed |
| US-4281151-A | ANTIALLERGENS, ANTIANAPHYLACTIC AGENTS | THE UPJOHN COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
| US-4248961-A | YELLOW COUPLER ACHIEVING GOOD COLOR DENSITY | CIBA-GEIGY AG (CH) | 1981-02-03 | — | — | US | disclosed |
| US-4186127-A | ANTIALLERGENS | THE UPJOHN COMPANY (US) | 1980-01-29 | — | — | US | disclosed |
| US-4159278-A | PROPHYAXIS, ANTIALLERGENS, SENSITIZATION | THE UPJOHN COMPANY (US) | 1979-06-26 | — | — | US | disclosed |
| US-4095028-A | PROPHYLAXIS, ALLERGIES | THE UPJOHN COMPANY (US) | 1978-06-13 | — | — | US | disclosed |
| US-4089973-A | Cyano phenylene dioxamic acid compounds used in the treatment of allergy | THE UPJOHN COMPANY (US) | 1978-05-16 | — | — | US | disclosed |
| US-3993679-A | ANTIALLERGY | THE UPJOHN COMPANY (US) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052421-A1 | Conjugation agent | STS, TST, SULT1A1 | GPR35 2971/4885VCAM1 3307/4885ALDH1A1 671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.